Velicept Therapeutics, Inc. — Form D
Velicept Therapeutics, Inc. of WAYNE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-19. The offering totals $9.2M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-11-19
- Form: D
- Accession: 0001659819-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $9.2M
- Amount sold: $6.0M
- Remaining: $3.2M
- Minimum investment: $1
- Investors: 5
- Date of first sale: 2019-11-05
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-353767
Issuer
- Name: Velicept Therapeutics, Inc.
- CIK: 0001659819
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 640 LEE ROAD, SUITE 119, WAYNE, PA, 19087
- Phone: 484-318-2988
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Cory S Freedland | Director | Wayne, PA |
| David Becker Hirsch, M.D. | Director | Wayne, PA |
| Aidan S King, MBA, CFA | Director | Wayne, PA |
| Jill Becker Mast | Director | Wayne, PA |
| Scott S Morenstein | Director | San Diego, CA |
| Stephen S Tullman | Director | Wayne, PA |
| James C Walker | Director | Blue Bell, PA |
| Doug Becker Gessl | Executive Officer | Wayne, PA |
| James C Walker | Executive Officer | Blue Bell, PA |
| James Walker | Director | Chicago, IL |
| James Walker | Executive Officer | Chicago, IL |
| Stephen Tullman | Director | Malvern, PA |
| David Hirsch | Director | San Diego, CA |
| James Bennethum | Director | Rockville, MD |
| Scott Morenstein | Director | Mendham, NJ |
| Douglas Gessl | Executive Officer | Wayne, PA |
| Aidan King | Director | Dublin, L2 |
| Cory Freedman | Director | Palo Alto, CA |
Other filings by this issuer (3)
More